QNRX Quoin Pharmaceuticals, Ltd.

Nasdaq quoinpharma.com


$ 14.82 $ -3.45 (-19.17 %)    

Thursday, 16-Oct-2025 11:57:32 EDT
QQQ $ 602.86 $ -2.37 (-0.39 %)
DIA $ 461.90 $ -1.32 (-0.28 %)
SPY $ 664.09 $ -2.78 (-0.42 %)
TLT $ 90.90 $ 0.40 (0.44 %)
GLD $ 393.09 $ 1.93 (0.49 %)
$ 15.27
$ 17.38
$ 14.42 x 20
$ 14.95 x 10
$ 13.80 - $ 17.38
$ 5.01 - $ 54.95
581,674
na
3.23M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 quoin-pharmaceuticals-qnrx-stock-is-skyrocketing-friday-whats-going-on

Quoin Pharmaceuticals shares are trading higher Friday morning after the company announced a private placement financing of up ...

 quoin-pharma-announces-1045m-private-placement-including-165m-upfront-and-88m-in-warrant-linked-upside-priced-above-prior-close

Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceut...

 quoin-pharmaceuticals-q2-eps-628-beats-741-estimate

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.28) per share which beat the analyst consensus estimate of...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION